We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Medicines Discovery Catapult

News List

Chief.AI launches pay-as-you-go AI platform for drug discovery pharmaceutical-technology
July 27, 2021
Machine learning operations platform Chief.AI, in partnership with the Medicines Discovery Catapult, has launched the first no-code, pay-as-you-go artificial intelligence (AI) platform for drug discovery.
New alliance strives to advance human-based drug evaluation pharmatimes
November 09, 2018
Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool have announced plans...
Medicines Discovery Catapult and AstraZeneca collaborate for acoustic mist ionisation mass spectrometry pharmatimes
October 25, 2018
Medicines Discovery Catapult and AstraZeneca have announced they will team up to advance the adoption of Acoustic Mist Ionisation Mass Spectrometry (AMI-MS) within drug discovery.